4D MOLECULAR THERAPEUTICS INC has a total of 48 patent applications. It increased the IP activity by 78.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Australia and Brazil. Its main competitors in its focus markets biotechnology and pharmaceuticals are ALEX LEVITZKI MAN AND HOLDINGS LTD, REPLIMUNE LTD and HOBDEN ADRIAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 3 | |
#3 | Brazil | 3 | |
#4 | Canada | 3 | |
#5 | Chile | 3 | |
#6 | China | 3 | |
#7 | EPO (European Patent Office) | 3 | |
#8 | Israel | 3 | |
#9 | Republic of Korea | 3 | |
#10 | Singapore | 3 | |
#11 | WIPO (World Intellectual Property Organization) | 3 | |
#12 | Colombia | 2 | |
#13 | Costa Rica | 2 | |
#14 | Peru | 2 | |
#15 | Philippines | 2 | |
#16 | South Africa | 2 | |
#17 | Mexico | 1 | |
#18 | New Zealand | 1 | |
#19 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kotterman Melissa | 39 |
#2 | Schaffer David | 38 |
#3 | Kirn David H | 28 |
#4 | Kirn David | 10 |
#5 | Szymanski Paul | 9 |
#6 | Francis Peter | 9 |
#7 | David Schaffer | 6 |
#8 | Melissa Kotterman | 6 |
#9 | David H Kirn | 5 |
#10 | David Kirn | 1 |
Publication | Filing date | Title |
---|---|---|
AU2018372235A1 | Adeno-associated virus variant capsids and use for inhibiting angiogenesis | |
PE20201264A1 | VARIANTS OF ADENO-ASSOCIATED VIRUS CAPSIDS AND METHODS OF USE OF THEM | |
KR20190005223A | Adeno-associated virus mutant capsids and uses thereof |